Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer.

Responders presented lower level of Radscore at TP1 ( P < 0.01), and the difference was borderline significant in test set ( P = 0.05) ( Figure S2A ).

also in 11,409 other papers

Furthermore, Radscore between the two response groups had borderline significance with P value of 0.05 in the test set at TP1, suggesting that the radiomics signature might be slightly over-fitted to training set.

also in 7,017 other papers